Matthew McGrew - 11 Nov 2022 Form 4 Insider Report for DANAHER CORP /DE/ (DHR)

Role
EVP & Chief Financial Officer
Signature
/s/ James F. O'Reilly, attorney-in-fact for Matthew McGrew
Issuer symbol
DHR
Transactions as of
11 Nov 2022
Net transactions value
-$4,118,964
Form type
4
Filing time
14 Nov 2022, 16:01:34 UTC
Previous filing
31 Oct 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DHR Common Stock Options Exercise $447,104 +7,722 +26% $57.90* 37,356 11 Nov 2022 Direct
transaction DHR Common Stock Sale $2,118,685 -7,722 -21% $274.37 29,634 11 Nov 2022 Direct
transaction DHR Common Stock Options Exercise $635,777 +11,213 +38% $56.70* 40,847 11 Nov 2022 Direct
transaction DHR Common Stock Sale $3,083,160 -11,213 -27% $274.96 29,634 11 Nov 2022 Direct F1
holding DHR Common Stock 8,698 11 Nov 2022 By 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DHR Employee stock option (right to buy) Options Exercise $0 -7,722 -100% $0.000000* 0 11 Nov 2022 Common Stock 7,722 $57.90 Direct F2
transaction DHR Employee stock option (right to buy) Options Exercise $0 -11,213 -100% $0.000000* 0 11 Nov 2022 Common Stock 11,213 $56.70 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.81 to $275.22, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4.
F2 One fifth of the options granted became exercisable on each of the first five anniversaries of the grant date, which was February 24, 2014.
F3 One third of the options granted became exercisable on each of the third, fourth and fifth anniversaries of the grant date, which was May 15, 2014.